Skip to main content
Digital Health logoLink to Digital Health
. 2024 Dec 18;10:20552076241306937. doi: 10.1177/20552076241306937

Validation of artificial intelligence-based quantitative coronary angiography

Do-Hyun Kim 1,*, Sun-Hwa Kim 1,*, Hyun-Wook Chu 1,2, Si-Hyuck Kang 1,3,, Chang-Hwan Yoon 1,3, Tae-Jin Youn 1,3, In-Ho Chae 1,3
PMCID: PMC11653446  PMID: 39698508

Abstract

Background

Coronary angiography is fundamental for the diagnosis and treatment of coronary artery disease. Manual quantitative coronary angiography (QCA) is accurate and reproducible; however, it is time-consuming and labor-intensive. However, recent advancements in artificial intelligence (AI) have enabled automated and rapid analysis of medical images, addressing the need for real-time quantitative coronary analysis.

Aims

This study aimed to evaluate the accuracy of AI-based QCA (AI-QCA) compared with that via manual QCA and clinician acceptance.

Methods

This retrospective, single-center study was conducted in two phases. Phase 1 was a pilot study comparing AI-QCA with manual QCA and visual estimation. It involved 15 patients who underwent coronary angiography at Seoul National University Bundang Hospital between September 2011 and July 2021. Phase 2 included a larger cohort of 762 patients, with 1002 coronary angiograms analyzed between May 2020 and April 2021.

Results

In phase 1, AI-QCA and manual QCA consistency varied among the observers, with AI-QCA showing superior consistency compared with visual estimation. However, a strong correlation between AI-QCA and manual-QCA was found in phase 2. AI-QCA accurately identified and quantitatively analyzed multiple lesions in the major vessels, providing results comparable with those of manual QCA.

Conclusions

AI-QCA demonstrated high concordance with manual QCA, offering real-time analysis and reduced workload. Therefore, AI-QCA has the potential to be a valuable tool for diagnosing and treating coronary artery disease, necessitating further studies for clinical validation.

Keywords: Coronary artery disease, deep learning, object detection, external validation, quantitative coronary angiography

Introduction

Coronary angiography is a fundamental tool for the diagnosis and treatment of coronary artery disease.1,2 Identifying the severity of stenosis using angiography is usually the starting point for assessing ischemia.3,4 The choice of a stent size is frequently based on only angiography.5,6 Manual quantitative coronary angiography (QCA) has proven to be accurate and reproducible for assessing vessel size and stenosis severity.79 Seldom is QCA used even in recent clinical trials, in which visual estimation has become the norm. 10 Additionally, its use in clinical practice is currently limited because it is time-consuming and labor-intensive. 5 Another reason is the introduction of intracoronary imaging, despite the relatively low penetration of invasive imaging methods.

Therefore, there is an unmet clinical need for a convenient, real-time quantitative coronary analysis. Recent advances in artificial intelligence (AI) have enabled automated and rapid analysis of medical images without human error.1113 Furthermore, understanding coronary angiography requires a long training period, even for cardiology specialists, making it a good candidate for AI applications.14,15 Therefore, in this study, we tested the accuracy of AI-based QCA (AI-QCA) compared with that via conventional manual QCA and evaluated its acceptance by clinicians.

Methods & materials

This retrospective analysis was conducted at a single center and included two separate phases. Phase 1 was a pilot study with a small sample size in which AI-QCA was compared with manual QCA and visual estimation. Phase 2 was conducted using a larger sample size to compare AI-QCA with manual QCA.

Enrollment criteria: Phase 1 pilot study

The phase 1 pilot study enrolled 15 patients aged ≥18 years who underwent coronary angiography and had significant stable coronary stenosis between September 2011 and July 2021 at the Seoul National University Bundang Hospital. Patients with total occlusion, acute myocardial infarction, or lesions located in a vessel with a diameter of <2.0 mm were excluded. The inclusion criteria were stratified by diseased coronary vessels and lesion length (LL). The coronary vessel included the left anterior descending artery, 4 left circumflex artery (LCX), or right coronary artery (RCA). However, the focal lesion was defined as <10 mm in LL and the diffuse one as ≥20 mm. Finally, the included patients were those with a single focal lesion at the LAD (n = 3), a diffuse lesion at the LAD (n = 3), a single focal lesion at the LCX (n = 3), a single focal lesion at the RCA (n = 3), or a diffuse lesion at the RCA (n = 3). The study protocol was approved and the mandate for obtaining informed consent was waived by the Seoul National Bundang Hospital Institutional Review Board (approval number: B-2109-708-112), because the research was deemed to present no more than minimal risk of harm to the participants.

Enrollment criteria: Phase 2 study

Phase 2 study was designed as a retrospective evaluation of coronary angiography with a larger sample size. Patients aged ≥18 years who underwent coronary angiography between May 2020 and April 2021 at Seoul National University Bundang Hospital and received at least one percutaneous coronary intervention were included in this study. Patients without full angiographic images before percutaneous coronary intervention, lesions in the left main coronary artery, vessels with a reference diameter of < 2 mm, and complete occlusion with thrombolysis in myocardial infarction flow grade 0 were excluded from the study. Patients with lesions unsuitable for AI-QCA or manual QCA were also excluded. Finally, 762 patients with 1002 coronary angiograms were selected out of the 1086 potentially eligible patients (Supplemental Figure 1). The study protocol was approved by the Seoul National Bundang Hospital Institutional Review Board (approval number B-2406-906-106). The Board determined that the research involved no more than minimal risk, and waived the requirement for informed consent.

Study variables and angiographic analysis

The study variables were the reference diameter (RD), proximal RD, distal RD, minimum lumen diameter (MLD), percent diameter stenosis (%DS), and LL. The investigator selected the best angle after reviewing all the coronary angiography images of each patient.

AI-QCA was performed using MPXA-2000 software (Medipixel, Seoul, Korea) following the vendor's protocol, which was approved by the Korean Ministry of Food and Drug Safety and the US Food and Drug Administration (regulation number: 21 CFR 892.2050). A brief overview of the AI-QCA process is shown in Figure 1. The software employs an ensemble of three neural networks—DeepLabV3+, U-Net++, and U2-Net—to perform vessel recognition and stenosis detection. 16 The deep-learning models were trained using 7658 images from 3129 patients who underwent coronary angiography at Asan Medical Center and Chungnam National University Hospital between February 2016 and November 2016.The software automatically chose the best frame and provided study variables without human intervention. Manual QCA was performed by an independent dedicated core laboratory using the CAAS software (Pie Medical, the Netherlands). An experienced interventional cardiologist performed the visual estimation.

Figure 1.

Figure 1.

Steps of AI-QCA process. (A) DICOM upload page for web-based AI-QCA version. (B) The best frame for QCA is recommended: 42nd frame out of 111 frames in this case. One can play the video by clicking the play button, or switch to other frames by clicking the forward/backward buttons or dragging the slide. When “Analyze” button is clicked, (C) AI-assisted QCA is performed. In this case, the most severe lesion in the mid-left anterior descending artery is shown first. P and D indicate proximal and distal lesion margins, respectively. Lesion length, diameter stenosis (DS), minimum lumen diameter (MLD), proximal reference diameter (D), distal reference diameter (D), and reference diameter (RD) are shown. Estimated lumen diameter along the vessel is shown in the diagram. (D) By clicking “S#1” tab, analysis on diagonal branch is presented. AI-QCA: artificial intelligence-based quantitative coronary angiography; DICOM, Digital Imaging and Communications in Medicine; QCA, quantitative coronary angiography.

Statistical analysis

In the phase 1 study, the results of AI-QCA were compared with those of manual QCA and visual estimation. Manual QCA and visual estimation were performed by multiple observers: manual QCA by three independent dedicated core labs and visual estimation by 4 independent cardiologists (2 with <5 years of independent experience and 2 with 5–15 years of experience). In addition, the cardiologists were requested to respond to the survey. Two QCA images were obtained: one acquired using AI-QCA and the other using manual QCA. The cardiologists were asked two questions: (1) Which image do you think was analyzed using AI-QCA? and (2) Which image do you agree with more? Interrater agreement for manual QCA and visual assessment was evaluated using intraclass correlation coefficients (ICC). The correlation between the two measurement methods was assessed using Pearson's correlation coefficient. The values from the three core laboratories and four cardiologists for each study variable were averaged and treated as a single value. ICC values were interpreted as poor, moderate, good, or excellent. 17

Phase 2 study compared the results of AI-QCA and manual QCA performed by a single observer. The correlation between the AI-QCA and manual QCA measurements was represented by a scatter plot and evaluated using Pearson's correlation coefficient. The Bland-Altman plot was used to visualize the agreement between the two methods. A subgroup analysis was performed based on vessel involvement.

Continuous variables are expressed as mean ± standard deviation, and categorical variables are expressed as numbers and percentages. The ICC and Pearson correlation coefficients and 95% confidence intervals were provided. All statistical analyses were performed using the R version 4.1.2 (http://www.R-project.org; R Foundation for Statistical Computing, Vienna, Austria).

Results

Phase 1: A pilot study

The phase 1 study was a pilot test with a small sample size that enrolled 15 patients with 15 simple lesions (1 lesion per 1 patient), stratified based on lesion location and length. The mean age of the 15 study participants was 70.5 years, and 8 (53.3%) were male patients. The ICC for manual QCA indicated moderate consistency across the three independent core laboratories, except for poor consistency for LL (Supplemental Table 1). Visual estimation by the four independent interventional cardiologists showed better consistency between each other for MLD, %DS, and LL.

The ICC between AI-QCA and manual-QCA varied among the observers (Table 1). In addition, different human observers showed agreement between 0.43 and 0.73 with each other. The correlation coefficients between AI-QCA and manual QCA were good or very good, except for LL (Table 2). Visual assessment also showed good correlation with manual QCA. The scatter plot and Bland-Altman plot for AI-QCA and manual QCA are shown in Supplemental Figures 2 and 3, respectively. The agreement level was numerically higher for AI-QCA and visual estimation, particularly for MLD and %DS (Supplemental Table 1).

Table 1.

Intraclass correlation coefficient indicating the consistency of lesion parameters between AI-QCA versus manual QCA by different observers in phase 1 pilot study (n = 15).

AI-QCA vs. Manual QCA (1) AI-QCA vs. Manual QCA (2) AI-QCA vs. Manual QCA (3) Between observers
ICC p ICC p ICC p ICC p
Proximal reference diameter (mm) 0.62 (0.17–0.85) 0.006 0.58 (0.12–0.84) 0.009 0.54 (0.06–0.82) 0.015 0.70 (0.44–0.87) <0.001
Distal reference diameter (mm) 0.58 (0.12–0.84) 0.009 0.72 (0.34–0.90) 0.001 0.80 (0.50–0.93) <0.001 0.55 (0.24–0.80) <0.001
Reference diameter (mm) 0.34 (−0.19–0.71) 0.101 0.75 (0.40–0.91) <0.001 0.75 (0.40–0.91) <0.001 0.60 (0.31–0.83) <0.001
Minimum lumen diameter (mm) 0.81 (0.51–0.93) <0.001 0.93 (0.81–0.98) <0.001 0.79 (0.48–0.92) <0.001 0.73 (0.49–0.89) <0.001
Percent diameter stenosis (%) 0.68 (0.27–0.88) 0.002 0.71 (0.32–0.89) 0.001 0.61 (0.16–0.85) 0.006 0.60 (0.31–0.83) <0.001
Lesion length (mm) 0.19 (−0.34–0.63) 0.238 0.19 (−0.34–0.63) 0.243 0.23 (−0.30–0.65) 0.195 0.43 (0.11–0.73) 0.003

AI-QCA: artificial intelligence-based quantitative coronary angiography; ICC: intraclass correlation coefficients.

Table 2.

Correlation coefficients and p values of lesion parameters of AI-QCA and visual assessment with manual QCA calculated using Pearson's method.

AI-QCA vs. manual QCA Visual assessment vs. manual QCA
Correlation coefficients p Correlation coefficients p
Proximal reference diameter (mm) 0.65 (0.21–0.87) 0.008 0.83 (0.54–0.94) <0.001
Distal reference diameter (mm) 0.85 (0.61–0.95) <0.001 0.79 (0.47–0.93) <0.001
Reference diameter (mm) 0.74 (0.36–0.91) 0.002 0.68 (0.26–0.89) 0.005
Minimum lumen diameter (mm) 0.93 (0.80–0.98) <0.001 0.85 (0.60–0.95) <0.001
Percent diameter stenosis (%) 0.77 (0.43–0.92) 0.001 0.83 (0.56–0.94) <0.001
Lesion length (mm) 0.26 (−0.29–0.68) 0.343 0.89 (0.70–0.96) <0.001

AI-QCA: artificial intelligence-based quantitative coronary angiography.

Figure 2.

Figure 2.

Scatter plot analysis between AI-QCA and manual QCA (phase 2). The plot shows strong correlations across all measurements: proximal RD, distal RD, RD, MLD, %DS, and LL. Gray regions indicate 95% confidence intervals for each measurement. AI-QCA, artificial intelligence-based quantitative coronary angiography; %DS, percent diameter stenosis; LL, lesion length; MLD, minimal lumen diameter; QCA, quantitative coronary angiography; RD, reference diameter.

Figure 3.

Figure 3.

Bland-Altman plot between AI-QCA and manual QCA (phase 2). The points are distributed around the central line (black solid line) and fall within the limits of agreement (red dashed lines), indicating a high concordance between the two methods. AI-QCA, artificial intelligence-based quantitative coronary angiography; QCA, quantitative coronary angiography.

A survey of participating cardiologists was conducted to determine how well they could distinguish between and agree on the two different QCA modalities. Notably, 43 of the 60 respondents (71.7%) correctly distinguished which images were created using AI-QCA or manual QCA; 42 (70.0%) replied that they agreed more with manual QCA than AI-QCA.

Phase 2: A retrospective study

Based on the results of the phase 1 pilot study, a retrospective analysis was conducted with a larger sample size. In total, 1002 coronary angiograms from 762 patients were included in this study. The mean age of the study population was 71.4 years (Table 3), and 73.4% were men. Notably, 23.5% of those who responded (533 participants) were current smokers. Hypertension, diabetes, and chronic kidney disease were prevalent in 57.1%, 36.5%, and 4.3% of the participants, respectively. The clinical diagnoses in the study population included acute coronary syndrome (41.6%) and stable coronary disease (58.4%). The lesion locations were 50.4%, 19.6%, and 30.5% in the left anterior descending, left circumflex, and right coronary arteries, respectively. The mean RD, MLD, %DS, and LL were 2.80 mm, 1.06 mm, 62%, and 23.6 mm, respectively (Table 4).

Table 3.

Clinical characteristics of the study population.

Characteristics (N = 762) N (%) or mean ± SD
Mean age (years) 71.4 ± 11.0
Body mass index 25.1 ± 3.4
Male sex 560 (73.4%)
Smokers 125 (23.5%)
Hypertension 435 (57.1%)
Diabetes mellitus 278 (36.5%)
Chronic kidney disease 33 (4.3%)
Laboratory findings
 Hemoglobin (g/dL) 13.5 (±1.7)
 Creatinine (mg/dL) 0.9 (±0.2)
 Total cholesterol (mg/dL) 159.2 (±37.6)
 HDL cholesterol (mg/dL) 48.3 (±11.8)
 Triglyceride (mg/dL) 119.1 (±58.1)
 LDL cholesterol (mg/dL) 90.3 (±31.8)
 HbA1c (%) 6.4 (±1.1)
Clinical diagnosis
 Stable coronary disease 445(58.4%)
 Unstable angina 105(13.8%)
 NSTEMI 159(20.9%)
 STEMI 53(6.9%)

HDL: high-density lipoprotein; LDL: low-density lipoprotein; NSTEMI: non-ST-elevation myocardial infarction; STEMI: ST-elevation myocardial infarction.

Table 4.

Characteristics of the study lesion.

Characteristics (N of lesions = 1002) N (%) or mean ± SD
Lesion location
 Left anterior descending artery 505 (50.4%)
 Left circumflex artery 191 (19.6%)
 Right coronary artery 306 (30.5%)
Lesion parameters
 Proximal reference diameter (mm) 2.95 ± 0.57
 Distal reference diameter (mm) 2.61 ± 0.56
 Reference diameter (mm) 2.80 ± 0.53
 Minimum lumen diameter (mm) 1.06 ± 0.44
 Percent diameter stenosis (%) 62.32 ± 13.41
 Lesion length (mm) 23.64 ± 11.26

AI-QCA showed strong to very strong correlations with statistical significance across the study variables, including proximal and distal RD, RD, MLD, and LL (Figure 2). The correlation coefficient for %DS was 0.55, indicating moderate correlation (Table 5). The Bland-Altman plots in Figure 3 reveal high concordance between the two methods for the study variables. The mean values of the proximal and distal RD, RD, MLD, %DS, and LL measured using AI-QCA were similar to those measured using manual QCA. The measurements were evenly distributed around the central line and were within the limits of agreement. Correlation was consistent across lesion locations (Supplemental Table 2).

Table 5.

Pearson's correlation coefficients of lesion parameters measured by AI-QCA and manual QCA in phase 2 study (N = 1002).

Correlation (95% CI) p
Proximal reference diameter (mm) 0.67 (0.63–0.70) <0.001
Distal reference diameter (mm) 0.82(0.80–0.84) <0.001
Reference diameter (mm) 0.80(0.78–0.82) <0.001
Minimum lumen diameter (mm) 0.67 (0.63–0.70) <0.001
Percent diameter stenosis (%) 0.55 (0.50–0.59) <0.001
Lesion length (mm) 0.84 (0.82–0.86) <0.001

AI-QCA: artificial intelligence-based quantitative coronary angiography; CI: confidence interval.

Discussion

This study demonstrated that lesion descriptions acquired using AI-QCA could correlate well with those acquired using manual QCA by human experts. We also found that manual QCA observers showed imperfect agreement and that the agreement between AI-QCA and manual QCA was similar to that between the observers. AI-QCA showed good agreement with the eyeball estimation of experienced cardiologists. Also, AI-QCA was highly practical because it could provide QCA results upon only a single click.

Recent advances in machine learning technology have boosted the clinical applications of AI in healthcare. However, understanding and interpreting coronary angiography images is challenging for several reasons. Complex three-dimensional cardiac structures can be represented by two-dimensional images. 18 Coronary angiography is performed as a video encompassing more than two to three heartbeats. Furthermore, a single still image does not contain sufficient information owing to heartbeats, respiratory movements, and patient motion artifacts. 19 Other reasons include the high variation in normal personal anatomy and discrepancies between anatomical and physiological abnormalities. 20 The AI-QCA application tested in this study was powered by machine learning algorithms that enabled the identification and segmentation of coronary arteries. Every QCA step, such as the best frame choice and lesion analysis, is fully automated to resemble manual QCA performed by human analysts.

These findings are consistent with those of previous studies. In Kim et al. 16 demonstrated a strong correlation between AI-QCA and manual QCA for identifying lumen diameters. Similarly, Moon et al. 21 showed a moderate to strong correlation between AI-QCA and intravascular ultrasound when analyzing coronary lesions with significant stenosis.

In addition, recent studies have suggested that the use of an AI system could help operators estimate lesion severity and reduce interobserver variability. Du et al. 22 also built a deep neural network model for the identification of coronary artery segments and recognition of lesion morphology, suggesting that it might help cardiologists flag and diagnose lesion severity and morphology during coronary intervention. Avram et al. 23 showed that multiple purpose-built neural networks accomplished automated analysis of coronary angiograms and suggested that it could increase standardization and reproducibility in angiographic coronary stenosis assessment. The same group developed a video-based AI model for coronary artery disease analysis demonstrating enhanced precision and reliability. 24

Our data suggest that AI-QCA has the potential to replace manual QCA in supporting clinicians in decision making. Lesion assessments made using AI-QCA were generally consistent with those made using manual QCA. The correlation between AI-QCA and manual-QCA was comparable with that of visual estimation by experienced human experts. Moreover, its advantages over manual QCA include the ability to provide real-time analysis that can be visualized within seconds and the reduction in workload on trained personnel.

The finding that the correlation between AI-QCA and manual-QCA was not perfect requires further discussion. In this study, we found that the agreement between human observers was far from perfect. This finding suggests that variations in manual QCA exist even among human experts in lesion selection and contour delineation. Notably, %DS by manual QCA is frequently used as a ground truth in studies23,24; however, earlier studies have highlighted the issue of significant interobserver bias in interpreting coronary angiography images. 15 The core machine learning algorithm of the AI-QCA was trained to replicate the manner in which human experts estimated coronary lesions. Manual QCA is not a perfect ground truth that every human observer agrees. However, AI-QCA can hardly resemble every manual QCA.

The present study has some limitations. First, this was a single-center study, and the findings cannot be generalized to other populations. Second, a priori sample size calculation was not performed in the two studies. Phase 1 study was planned with a small sample size and served as a pilot study. Phase 2 study intended to include approximately 1000 angiograms and enrolled all comers during a specific period with minimal exclusion criteria.

Conclusions

This study demonstrated that AI-QCA was highly concordant with manual QCA. Prompt and accurate lesion estimation using AI-QCA can aid clinicians in making better clinical decisions during coronary angiography and angioplasty. However, further studies are needed to validate its role in diagnosing and treating cardiovascular diseases when it is integrated into clinical practice.

Supplemental Material

sj-docx-1-dhj-10.1177_20552076241306937 - Supplemental material for Validation of artificial intelligence-based quantitative coronary angiography

Supplemental material, sj-docx-1-dhj-10.1177_20552076241306937 for Validation of artificial intelligence-based quantitative coronary angiography by Do-Hyun Kim, Sun-Hwa Kim, Hyun-Wook Chu, Si-Hyuck Kang, Chang-Hwan Yoon, Tae-Jin Youn and In-Ho Chae in DIGITAL HEALTH

Abbreviations

%DS

Percent diameter stenosis

AI

Artificial intelligence

AI-QCA

Artificial intelligence-based quantitative coronary angiography

ICC

Intraclass correlation coefficients

RD

Reference diameter

LL

Lesion length

MLD

Minimal lumen diameter

QCA

Quantitative coronary angiography

Footnotes

Author contributions: H-WC was involved in conceptualization, methodology, and Software; H-WC in data curation and writing—original draft preparation; D-HK and S-HK in visualization and investigation; S-HK in supervision; DHK and S-HK in software and validation; and S-HK, D-HK, and S-HK in writing—reviewing and editing. All authors reviewed the text and approved the final version of the manuscript for publication.

Consent to participate: The IRB waived the requirement for informed consent as the study was assessed to present only minimal risk to participants.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical considerations: Both study protocols were approved by the Institutional Review Board (IRB) of Seoul National University Bundang Hospital (Approval number: B-2406-906-106, B-2406-906-106). The IRB determined that this research involved no more than minimal risk to the participants.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Medipixel Inc. supported phase 1 of this study, and the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2023-00222910) supported phase 2. We extend our gratitude to the team at the Seoul National University Bundang Hospital for their assistance with data collection. We also thank Medipixel Inc. for their support with the AI-QCA software and the independent core laboratories and interventional cardiologists for their contributions to manual QCA and visual estimations.

Data availability: The datasets generated during and/or analyzed during the current study are not publicly available due privacy issues but are available from the corresponding author on reasonable request.

Impact on daily practice: AI-QCA improves diagnostic accuracy and efficiency through real-time analysis, significantly reducing the workload on clinicians. This technology enables rapid decision making and provides standardized, consistent results, making it a beneficial tool for the diagnosis and treatment of coronary artery disease. Integrating AI-QCA into clinical practice could enhance the quality of patient care and assist clinicians in making informed decisions, potentially leading to better patient outcomes.

Supplemental material: Supplemental material for this article is available online.

References

  • 1.Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology appropriate use criteria task force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69: 2212–2241. [DOI] [PubMed] [Google Scholar]
  • 2.Herzog C, Zangos S, Zwerner P, et al. CT of coronary artery disease. J Thorac Imaging 2007; 22: 40–48. [DOI] [PubMed] [Google Scholar]
  • 3.Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2022; 145: e4–e17. [DOI] [PubMed] [Google Scholar]
  • 4.Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87–165. [DOI] [PubMed] [Google Scholar]
  • 5.Shin DH, Kang HJ, Jang JS, et al. The current status of percutaneous coronary intervention in Korea: based on year 2014 & 2016 cohort of Korean percutaneous coronary intervention (K-PCI) registry. Korean Circ J 2019; 49: 1136–1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Räber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 2018; 39: 3281–3300. [DOI] [PubMed] [Google Scholar]
  • 7.Meijboom WB, Van Mieghem CA, Van Pelt N, et al. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 2008; 52: 636–643. [DOI] [PubMed] [Google Scholar]
  • 8.Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280–288. [DOI] [PubMed] [Google Scholar]
  • 9.Hermiller JB, Cusma JT, Spero LA, et al. Quantitative and qualitative coronary angiographic analysis: review of methods, utility, and limitations. Cathet Cardiovasc Diagn 1992; 25: 110–131. [DOI] [PubMed] [Google Scholar]
  • 10.Fearon WF, Zimmermann FM, De Bruyne B, et al. Fractional flow reserve–guided PCI as compared with coronary bypass surgery. N Eng J Med 2022; 386: 128–137. [DOI] [PubMed] [Google Scholar]
  • 11.Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Eng J Med 2019; 380: 1347–1358. [DOI] [PubMed] [Google Scholar]
  • 12.Yang S, Kweon J, Roh JH, et al. Deep learning segmentation of major vessels in X-ray coronary angiography. Sci Rep 2019; 9: 16897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Menezes MN, Silva JL, Silva B, et al. Coronary X-ray angiography segmentation using Artificial Intelligence: a multicentric validation study of a deep learning model. Int J Cardiovasc Imaging 2023; 39(7): 1385–1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Menezes MN, Silva B, Silva JL, et al. Segmentation of X-ray coronary angiography with an artificial intelligence deep learning model: Impact in operator visual assessment of coronary stenosis severity. Catheter Cardiovasc Interv 2023; 102(4): 631–640. [DOI] [PubMed] [Google Scholar]
  • 15.Green P, Frobisher P, Ramcharitar S. Optimal angiographic views for invasive coronary angiography: a guide for trainees. Br J Cardiol 2016; 23: 110–113. [Google Scholar]
  • 16.In Kim Y, Roh JH, Kweon J, et al. Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning. Int J Cardiol 2024; 405: 131945. [DOI] [PubMed] [Google Scholar]
  • 17.Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016; 15: 155–163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Çimen S, Gooya A, Grass M, et al. Reconstruction of coronary arteries from X-ray angiography: a review. Med Image Anal 2016; 32: 46–68. [DOI] [PubMed] [Google Scholar]
  • 19.Ovalle-Magallanes E, Avina-Cervantes JG, Cruz-Aceves I, et al. Transfer learning for stenosis detection in X-ray coronary angiography. Mathematics 2020; 8: 1510. [Google Scholar]
  • 20.Toth GG, Toth B, Johnson NP, et al. Revascularization decisions in patients with stable angina and intermediate lesions: results of the International Survey on Interventional Strategy. Circ Cardiovasc Interven 2014; 7: 751–759. [DOI] [PubMed] [Google Scholar]
  • 21.Moon IT, Kim SH, Chin JY, et al. Accuracy of artificial intelligence-based automated quantitative coronary angiography compared to intravascular ultrasound: retrospective cohort study. JMIR Cardio 2023; 7: e45299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Du T, Xie L, Zhang H, et al. Training and validation of a deep learning architecture for the automatic analysis of coronary angiography. EuroIntervention 2021; 17: 32–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Avram R, Olgin JE, Ahmed Z, et al. CathAI: fully automated coronary angiography interpretation and stenosis estimation. NPJ Digit Med 2023; 6: 142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Labrecque Langlais É, Corbin D, Tastet O, et al. Evaluation of stenoses using AI video models applied to coronary angiography. NPJ Digit Med 2024; 7: 138. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-docx-1-dhj-10.1177_20552076241306937 - Supplemental material for Validation of artificial intelligence-based quantitative coronary angiography

Supplemental material, sj-docx-1-dhj-10.1177_20552076241306937 for Validation of artificial intelligence-based quantitative coronary angiography by Do-Hyun Kim, Sun-Hwa Kim, Hyun-Wook Chu, Si-Hyuck Kang, Chang-Hwan Yoon, Tae-Jin Youn and In-Ho Chae in DIGITAL HEALTH


Articles from Digital Health are provided here courtesy of SAGE Publications

RESOURCES